Immunovant, Inc. (IMVT) — Financial ratios
Profitability, liquidity, leverage, and valuation ratios for Immunovant, Inc., with annual and quarterly history.
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Valuation | ||||||
| P/E Ratio | -6.26x | -16.83x | -9.05x | -3.86x | -13.10x | -10.13x |
| P/B Ratio | 3.66x | 7.07x | 5.27x | 1.29x | 3.60x | 7.15x |
| P/S Ratio | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x |
| Profitability | ||||||
| Gross Margin | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Operating Margin | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net Margin | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| EBITDA Margin | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Liquidity | ||||||
| Current Ratio | 11.16x | 13.70x | 9.34x | 11.52x | 21.79x | 7.12x |
| Quick Ratio | 11.16x | 13.70x | 9.34x | 11.52x | 21.79x | 7.12x |
| Leverage | ||||||
| Debt/Equity | 0.00x | 0.00x | 0.00x | 0.01x | 0.01x | 0.03x |
YoY = year-over-year change. Source: FMP..